Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial

Next Previous
Trial Profile

Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abatacept (Primary) ; Alemtuzumab; Antithymocyte globulin; Ciclosporin; Diphenhydramine; Diphenhydramine; Fludarabine; Melphalan; Methotrexate; Methylprednisolone; Mycophenolate mofetil; Paracetamol; Pethidine; Sirolimus; Tacrolimus; Thiotepa
  • Indications Graft-versus-host disease
  • Focus Adverse reactions

    • Most Recent Events

    • 04 Aug 2021 Planned End Date changed from 30 Jun 2021 to 30 Dec 2021.
    • 04 Aug 2021 Planned primary completion date changed from 30 Jun 2021 to 30 Dec 2021.
    • 07 Jul 2020 Status changed from recruiting to active, no longer recruiting.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top